-transparent.png){kind=logo}
The capacity of chronic lymphocytic leukemia cells to concentrate prednisolone has been evaluated in vivo and in vitro employing a radioimmunoassay for prednisolone. No evidence to suggest that leukemia cells are capable of selectively concentrating glucocorticoid was found. The relative uptake of glucocorticoid by leukemia cells was found to be greater in vitro than in vivo. This may be attributable to differences in steroid bioavailability to cells. Substantially lower levels than previously reported of free prednisolone were found in plasma of patients receiving oral treatment with prednisolone. This may result from the failure in previous studies to remove derivatives of prednisolone and other steroids prior to assay for hormones.
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
January 1991,
Leukemia & lymphoma,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
November 1982,
Gut,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
May 1993,
Leukemia & lymphoma,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
April 2001,
Cancer letters,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
March 2011,
Blood,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
January 1969,
Haematologica Latina,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
September 2002,
Cancer,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
November 1962,
The American journal of roentgenology, radium therapy, and nuclear medicine,
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
June 2001,
Deutsche medizinische Wochenschrift (1946),
N S Panesar, and
C C Bird, and
B E Roberts, and
J A Child
January 2013,
Advanced biomedical research,
